Dexcom Inc (DXCM)
71.94 x 1 72.21 x 1
Post-market by (Cboe BZX)
72.13 -1.42 (-1.93%) 03/26/25 [NASDAQ]
71.94 x 1 72.21 x 1
Post-market 72.13 unch (unch) 16:34 ET
for Wed, Mar 26th, 2025
Try Excel 
Watch
-
Add or delete the symbol from one or more Watchlists.
-
Create New Watchlist
This name already in use.
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Sales | 4,033,000 | 3,622,300 | 2,909,800 | 2,448,500 | 1,926,700 |
| Cost of Goods | 1,594,800 | 1,333,400 | 1,026,700 | 768,000 | 646,600 |
| Gross Profit | 2,438,200 | 2,288,900 | 1,883,100 | 1,680,500 | 1,280,100 |
| Operating Expenses | 1,839,000 | 1,691,600 | 1,492,600 | 1,414,700 | 981,200 |
| Operating Income | 600,000 | 597,700 | 391,200 | 265,800 | 299,500 |
| Interest Expense | 0 | 0 | 0 | 0 | 17,700 |
| Other Income | 109,000 | 112,700 | -400 | -9,000 | 16,100 |
| Pre-tax Income | 709,000 | 710,400 | 390,800 | 256,800 | 297,900 |
| Income Tax | 132,800 | 168,900 | 49,600 | 39,900 | -251,800 |
| Net Income Continuous | 576,200 | 541,500 | 341,200 | 216,900 | 549,700 |
| Net Income | $576,200 | $541,500 | $341,200 | $216,900 | $549,700 |
| EPS Basic Total Ops | 1.46 | 1.40 | 0.88 | 0.56 | 1.46 |
| EPS Basic Continuous Ops | 1.46 | 1.40 | 0.88 | 0.56 | 1.46 |
| EPS Diluted Total Ops | 1.42 | 1.30 | 0.82 | 0.53 | 1.33 |
| EPS Diluted Continuous Ops | 1.40 | 1.27 | 0.80 | 0.51 | 1.31 |
| EPS Diluted Before Non-Recurring Items | 1.64 | 1.52 | 0.87 | 0.67 | 0.78 |
| EBITDA(a) | $817,700 | $783,700 | $547,100 | $367,800 | $366,600 |